Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

TBIO - Telesis Bio Inc


IEX Last Trade
3.43
0.070   2.041%

Share volume: 40,605
Last Updated: Fri 30 Aug 2024 04:53:43 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$3.36
0.07
2.08%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
21%
Profitability 0%
Dept financing 15%
Liquidity 75%
Performance 30%
Company vs Stock growth
vs
Performance
5 Days
-0.58%
1 Month
-13.42%
3 Months
-6.68%
6 Months
-66.07%
1 Year
-84.92%
2 Year
70.15%
Key data
Stock price
$3.43
P/E Ratio 
-0.12
DAY RANGE
N/A - N/A
EPS 
-$39.24
52 WEEK RANGE
$3.03 - $25.20
52 WEEK CHANGE
-$0.85
MARKET CAP 
6.063 M
YIELD 
N/A
SHARES OUTSTANDING 
1.773 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$20,542
AVERAGE 30 VOLUME 
$191,228
Company detail
CEO:
Region: US
Website: sgidna.com
Employees: 76
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.

Recent news